JAK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A1L429 | Y10 | Sugiyama | GAGE12B; GAGE12C; GAGE12D; GAGE12E | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NDE8 | Y10 | Sugiyama | GAGE12H | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| A6NER3 | Y10 | Sugiyama | GAGE12J | ___________MSWRGRsTyyWPRPRPYVQPPEMIGPMRPE |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O14910 | S135 | Sugiyama | LIN7A MALS1 VELI1 | DEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGDQL |
| O14910 | Y133 | Sugiyama | LIN7A MALS1 VELI1 | KTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGD |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14979 | Y167 | Sugiyama | HNRNPDL HNRPDL JKTBP | DGKMFIGGLSWDTsKKDLtEyLSRFGEVVDCtIKTDPVTGR |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60814 | Y43 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O76087 | Y10 | Sugiyama | GAGE7 GAGE12I GAGE7B | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| O95714 | S2928 | Sugiyama | HERC2 | ILLGRIRAEEEDLAAVPFLAsDNEEEEDEKGNSGsLIRKKA |
| O95817 | T242 | Sugiyama | BAG3 BIS | QPsFHQAQKTHyPAQQGEyQtHQPVyHKIQGDDWEPRPLRA |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P02786 | Y152 | Sugiyama | TFRC | sEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVENQ |
| P04080 | Y97 | Sugiyama | CSTB CST6 STFB | NKPLtLsNyQTNKAKHDELtyF___________________ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05362 | Y455 | Sugiyama | ICAM1 | GtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNVL |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07711 | Y311 | Sugiyama | CTSL CTSL1 | DNNKYWLVKNsWGEEWGMGGyVKMAKDRRNHCGIAsAAsyP |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y465 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IKLGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMK |
| P07900 | Y466 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KLGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKE |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08758 | Y94 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | TGKFEKLIVALMKPSRLyDAyELKHALKGAGTNEKVLtEII |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P0CL80 | Y10 | Sugiyama | GAGE12F | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| P0DSO3 | Y10 | Sugiyama | GAGE4 | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| P10721 | S943 | Sugiyama | KIT SCFR | LIEKQISEstNHIysNLANCsPNRQKPVVDHSVRINsVGst |
| P10721 | Y936 | Sugiyama | KIT SCFR | TFKQIVQLIEKQISEstNHIysNLANCsPNRQKPVVDHSVR |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | S544 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KYKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKIND |
| P11142 | Y134 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FYPEEVSSMVLTKMKEIAEAyLGKtVTNAVVtVPAyFNDsQ |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P11940 | Y291 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | ERQTELKRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLR |
| P11940 | Y297 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLRKEFsPF |
| P13073 | Y38 | Sugiyama | COX4I1 COX4 | SVCVRAHESVVKsEDFsLPAyMDRRDHPLPEVAHVKHLSAS |
| P13639 | Y443 | Sugiyama | EEF2 EF2 | TGLKVRIMGPNytPGKKEDLyLKPIQRTILMMGRYVEPIED |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | Y106 | Sugiyama | PRKCSH G19P1 | yIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREs |
| P14625 | Y401 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VTFKSILFVPTSAPRGLFDEyGsKKSDYIKLYVRRVFITDD |
| P14784 | Y364 | SIGNOR|iPTMNet|EPSD | IL2RB IL15RB | PEPASLSSNHSLTSCFTNQGyFFFHLPDALEIEACQVyFTy |
| P14784 | Y418 | SIGNOR | IL2RB IL15RB | GAPTGSSPQPLQPLSGEDDAyCTFPSRDDLLLFSPSLLGGP |
| P14784 | Y536 | SIGNOR | IL2RB IL15RB | PPGQGEFRALNARLPLNtDAyLSLQELQGQDPTHLV_____ |
| P15260 | Y457 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | IFNGR1 | EIKTEGQELITVIKAPTSFGyDKPHVLVDLLVDDSGKESLI |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17676 | Y139 | Sugiyama | CEBPB TCF5 PP9092 | SDLFSDDYGGKNCKKPAEyGyVsLGRLGAAKGALHPGCFAP |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P19525 | Y101 | iPTMNet|EPSD | EIF2AK2 PKR PRKR | AVsPLLLtttNssEGLsMGNyIGLINRIAQKKRLTVNYEQC |
| P19525 | Y293 | iPTMNet|EPSD | EIF2AK2 PKR PRKR | IGSGGFGQVFKAKHRIDGKTyVIKRVKYNNEKAEREVKALA |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23458 | T901 | Sugiyama | JAK1 JAK1A JAK1B | LGEGHFGKVELCRyDPEGDNtGEQVAVKSLKPESGGNHIAD |
| P23458 | Y1034 | Sugiyama | JAK1 JAK1A JAK1B | EHQVKIGDFGLTKAIETDKEyyTVKDDRDSPVFWYAPECLM |
| P23458 | Y1035 | Sugiyama | JAK1 JAK1A JAK1B | HQVKIGDFGLTKAIETDKEyyTVKDDRDSPVFWYAPECLMQ |
| P23458 | Y894 | Sugiyama | JAK1 JAK1A JAK1B | FLKRIRDLGEGHFGKVELCRyDPEGDNtGEQVAVKSLKPES |
| P23458 | Y933 | Sugiyama | JAK1 JAK1A JAK1B | ESGGNHIADLKKEIEILRNLyHENIVKYKGICTEDGGNGIK |
| P23458 | Y993 | Sugiyama | JAK1 JAK1A JAK1B | NKINLKQQLKYAVQICKGMDyLGSRQYVHRDLAARNVLVES |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P24752 | Y90 | Sugiyama | ACAT1 ACAT MAT | IAIQGAIEKAGIPKEEVKEAyMGNVLQGGEGQAPTRQAVLG |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27540 | Y561 | Sugiyama | ARNT BHLHE2 | PLEKSDGLFAQDRDPRFsEIyHNINADQSKGISSSTVPATQ |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P27816 | Y47 | Sugiyama | MAP4 | AtLEAEAFDDVVGETVGKTDyIPLLDVDEKtGNsESKKKPC |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29597 | Y1054 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | TYK2 | DRLVKIGDFGLAKAVPEGHEyyRVREDGDsPVFWyAPECLK |
| P29597 | Y1055 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | TYK2 | RLVKIGDFGLAKAVPEGHEyyRVREDGDsPVFWyAPECLKE |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30086 | S104 | Sugiyama | PEBP1 PBP PEBP | WHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLV |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y356 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FVMQEEFsRDGKALERFLQDyFDGNLKRyLKsEPIPESNDG |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S31 | Sugiyama | HSPA4 APG2 HSPH2 | QSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGAA |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P35568 | Y612 | iPTMNet|EPSD | IRS1 | LERRGGHHRPDsstLHtDDGyMPMsPGVAPVPSGRKGsGDy |
| P35568 | Y632 | iPTMNet|EPSD | IRS1 | yMPMsPGVAPVPSGRKGsGDyMPMsPKsVSAPQQIINPIRR |
| P35568 | Y662 | iPTMNet|EPSD | IRS1 | APQQIINPIRRHPQRVDPNGyMMMSPSGGCSPDIGGGPSSS |
| P35568 | Y732 | iPTMNet|EPSD | IRS1 | PHPKPPVESSGGKLLPCTGDyMNMSPVGDSNTSSPSDCYYG |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40763 | Y705 | SIGNOR|EPSD | STAT3 APRF | KyCRPEsQEHPEADPGsAAPyLKTKFICVtPttCsNtIDLP |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P42224 | Y701 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | STAT1 | YSRPKEAPEPMELDGPKGtGyIKtELIsVsEVHPSRLQttD |
| P42226 | Y641 | ELM | STAT6 | KDEAFRSHYKPEQMGKDGRGyVPATIKMTVERDQPLPTPEL |
| P42229 | Y694 | PSP | STAT5A STAT5 | PKDEVFSKYYTPVLAKAVDGyVKPQIKQVVPEFVNASADAG |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P46776 | Y52 | Sugiyama | RPL27A | RGNAGGLHHHRINFDKyHPGyFGKVGMKHYHLKRNQsFCPt |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P47224 | Y114 | Sugiyama | RABIF MSS4 RASGRF3 | CADCEIGPIGWHCLDDKNSFyVALERVSHE___________ |
| P47756 | Y232 | Sugiyama | CAPZB | NIGRLVEDMENKIRstLNEIyFGKTKDIVNGLRSVQTFADK |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49207 | T35 | Sugiyama | RPL34 | tASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGRLRG |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P52630 | Y690 | SIGNOR|ELM|iPTMNet|EPSD | STAT2 | RDEAFGCYYQEKVNLQERRKyLKHRLIVVSNRQVDELQQPL |
| P53634 | Y438 | Sugiyama | CTSC CPPI | SGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIEsIAVAAt |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P57053 | Y43 | Sugiyama | H2BC12L H2BFS H2BS1 | QKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y43 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P61024 | Y7 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ______________MSHKQIyysDKyDDEEFEyRHVMLPKD |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61081 | Y177 | Sugiyama | UBE2M UBC12 | RRLFEQNVQRSMRGGyIGstyFERCLK______________ |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61604 | T79 | Sugiyama | HSPE1 | EIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDILGK |
| P61604 | Y100 | Sugiyama | HSPE1 | KVVLDDKDyFLFRDGDILGKyVD__________________ |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62312 | Y72 | Sugiyama | LSM6 | VNGQLKNKyGDAFIRGNNVLyIstQKRRM____________ |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62807 | Y43 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | QKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62899 | Y25 | Sugiyama | RPL31 | KKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRA |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | Y197 | Sugiyama | YBX1 NSEP1 YB1 | APEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGEV |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y254 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68431 | Y42 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ATKAARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELL |
| P83731 | Y11 | Sugiyama | RPL24 | __________MKVELCsFsGyKIYPGHGRRYARTDGKVFQF |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05639 | Y254 | Sugiyama | EEF1A2 EEF1AL STN | TILPPTRPTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRP |
| Q06124 | Y304 | SIGNOR | PTPN11 PTP2C SHPTP2 | PFDHTRVVLHDGDPNEPVSDyINANIIMPEFETKCNNSKPK |
| Q06124 | Y327 | SIGNOR | PTPN11 PTP2C SHPTP2 | ANIIMPEFETKCNNSKPKKSyIATQGCLQNTVNDFWRMVFQ |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07955 | Y189 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | TYAVRKLDNTKFRsHEGEtAyIRVKVDGPRsPsyGRsRsRs |
| Q13069 | Y10 | Sugiyama | GAGE5 | ___________MSWRGRsTyyWPRPRRYVQPPEVIGPMRPE |
| Q13070 | Y10 | Sugiyama | GAGE6 | ___________MSWRGRsTyyWPRPRRYVQPPEVIGPMRPE |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13546 | Y384 | PSP | RIPK1 RIP RIP1 | EHPQEENEPSLQSKLQDEANyHLyGsRMDRQTKQQPRQNVA |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13573 | Y176 | Sugiyama | SNW1 SKIIP SKIP | SQKVAAAMPVRAADKLAPAQyIRytPsQQGVAFNsGAKQRV |
| Q13651 | Y446 | SIGNOR|iPTMNet|EPSD | IL10RA IL10R | SPPEPEVPGEEDPAAVAFQGyLRQTRCAEEKATKTGCLEEE |
| Q13651 | Y496 | SIGNOR|iPTMNet|EPSD | IL10RA IL10R | KFGRCLVDEAGLHPPALAKGyLKQDPLEMTLASSGAPTGQW |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | Y141 | Sugiyama | CTTN EMS1 | FGGKFGVQMDRVDQsAVGFEyQGKtEKHAsQKDyssGFGGK |
| Q14247 | Y215 | Sugiyama | CTTN EMS1 | FGGKyGIDKDKVDKsAVGFEyQGKtEKHESQKDyVKGFGGK |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14765 | Y693 | ELM | STAT4 | KHYSSQPCEVSRPTERGDKGyVPSVFIPISTIRSDSTEPHs |
| Q15293 | Y140 | Sugiyama | RCN1 RCN | VAKVWKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssD |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15424 | Y723 | Sugiyama | SAFB HAP HET SAFB1 | EQERRPAVRRPYDLDRRDDAyWPEAKRAALDERYHSDFNRQ |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15555 | Y268 | Sugiyama | MAPRE2 RP1 | NEQVHsLKLALEGVEKERDFyFGKLREIELLCQEHGQENDD |
| Q15691 | Y217 | Sugiyama | MAPRE1 | MQQVNVLKLtVEDLEKERDFyFGKLRNIELICQENEGENDP |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q4VXU2 | Y291 | Sugiyama | PABPC1L C20orf119 | ERQNELKRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLR |
| Q4VXU2 | Y297 | Sugiyama | PABPC1L C20orf119 | KRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLRKEFSPY |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF3 | Y58 | Sugiyama | HSP90B2P GRP94B GRP94P1 TRAP1 | VTFKSILFVPTFVPRGLFDEyGsKKSDYIKLYVRCVFITDD |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q5JTH9 | Y1251 | Sugiyama | RRP12 KIAA0690 | AEYKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQG |
| Q5JTH9 | Y1253 | Sugiyama | RRP12 KIAA0690 | YKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQGQF |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5QNW6 | Y43 | Sugiyama | H2BC18 HIST2H2BF | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q5T035 | T62 | Sugiyama | FAM120A2P C9orf129 | yPysLSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyER |
| Q5T035 | Y67 | Sugiyama | FAM120A2P C9orf129 | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPIN |
| Q5VTE0 | Y254 | Sugiyama | EEF1A1P5 EEF1AL3 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6ZN18 | S206 | Sugiyama | AEBP2 | DEGYGTGGGGSSATSGGRRGsLEMssDGEPLSRMDSEDSIS |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8TDD1 | Y681 | Sugiyama | DDX54 | GPNRGAKRRREEARQRDQEFyIPyRPKDFDSERGLsIsGEG |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q93079 | Y43 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q96C90 | Y29 | Sugiyama | PPP1R14B PLCB3N PNG | GAALAAPAPGPGsGGPGPRVyFQsPPGAAGEGPGGADDEGP |
| Q96CT7 | Y38 | Sugiyama | CCDC124 | RRAEAKAAADAKKQKELEDAyWKDDDKHVMRKEQRKEEKEK |
| Q96EB6 | Y280 | EPSD|PSP | SIRT1 SIR2L1 | TGAGVSVSCGIPDFRSRDGIyARLAVDFPDLPDPQAMFDIE |
| Q96EB6 | Y301 | EPSD|PSP | SIRT1 SIR2L1 | ARLAVDFPDLPDPQAMFDIEyFRKDPRPFFKFAKEIYPGQF |
| Q99470 | Y187 | Sugiyama | SDF2 | GRPISGQKEVHGMAQPSQNNyWKAMEGIFMKPSELLKAEAH |
| Q99683 | Y718 | EPSD|PSP | MAP3K5 ASK1 MAPKKK5 MEKK5 | RDLSNQVRIAIKEIPERDSRySQPLHEEIALHKHLKHKNIV |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99877 | Y43 | Sugiyama | H2BC15 H2BFD HIST1H2BN | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y43 | Sugiyama | H2BC14 H2BFE HIST1H2BM | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y43 | Sugiyama | H2BC13 H2BFC HIST1H2BL | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q9BRL6 | Y44 | Sugiyama | SRSF8 SFRS2B SRP46 | RtsPDsLRRVFEKYGRVGDVyIPREPHTKAPRGFAFVRFHD |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9HAP6 | S120 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | DEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGDQL |
| Q9HAP6 | Y118 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | KTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGD |
| Q9HB71 | Y165 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | VKTDTVLILCRKKVENTRWDyLtQVEKECKEKEKPsYDtEt |
| Q9HCN8 | Y81 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | GSGSGQQSVtGVEAsDDANSyWRIRGGSEGGCPRGSPVRCG |
| Q9NRF2 | Y439 | GPS6 | SH2B1 KIAA1299 SH2B | PSQDLLLGPSESNDRLSQGAyGGLSDRPSASISPSSASIAA |
| Q9NRF2 | Y494 | GPS6 | SH2B1 KIAA1299 SH2B | PRIPIEEGPPTGTVHPLSAPyPPLDTPETATGSFLFQGEPE |
| Q9NUP9 | S120 | Sugiyama | LIN7C MALS3 VELI3 | EEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGDQL |
| Q9NUP9 | Y118 | Sugiyama | LIN7C MALS3 VELI3 | KTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGD |
| Q9NYF8 | Y219 | Sugiyama | BCLAF1 BTF KIAA0164 | IDEFNKssAtsGDIWPGLsAyDNsPRsPHsPsPIAtPPSQS |
| Q9NZB2 | T413 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | yPysLSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyER |
| Q9NZB2 | Y418 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPIN |
| Q9NZJ5 | Y585 | SIGNOR|PSP | EIF2AK3 PEK PERK | yDsVSGEANDSSWNDIKNSGyISRYLTDFEPIQCLGRGGFG |
| Q9NZJ5 | Y619 | SIGNOR|PSP | EIF2AK3 PEK PERK | LGRGGFGVVFEAKNKVDDCNyAIKRIRLPNRELAREKVMRE |
| Q9NZQ7 | Y112 | PSP | CD274 B7H1 PDCD1L1 PDCD1LG1 PDL1 | LSLGNAALQITDVKLQDAGVyRCMISYGGADYKRITVKVNA |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UJU6 | Y16 | Sugiyama | DBNL CMAP SH3P7 PP5423 | _____MAANLSRNGPALQEAyVRVVtEKsPtDWALFTyEGN |
| Q9UMX5 | Y65 | Sugiyama | NENF CIR2 SPUF | RLFtEEELARYGGEEEDQPIyLAVKGVVFDVtSGKEFYGRG |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y4H2 | Y742 | Sugiyama | IRS2 | ASGGGYKAssPAEssPEDsGyMRMWCGSKLSMEHADGKLLP |
| Q9Y5X2 | Y126 | SIGNOR|EPSD|PSP | SNX8 | VYRRYNDFVVFQEMLLHKFPyRMVPALPPKRMLGADREFIE |
| Q9Y5X2 | Y95 | SIGNOR|EPSD|PSP | SNX8 | DTVQVELIPEKKGLFLKHVEyEVSSQRFKSSVYRRYNDFVV |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.096546e-13 | 12.149 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.522094e-12 | 11.124 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.757834e-09 | 8.755 | 1 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.347721e-09 | 8.134 | 1 | 1 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.031923e-08 | 7.986 | 1 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.258257e-08 | 7.139 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.420912e-08 | 7.192 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.012687e-08 | 7.096 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.012687e-08 | 7.096 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.216756e-08 | 7.035 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.216756e-08 | 7.035 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.591667e-08 | 7.018 | 1 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.212883e-07 | 6.655 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.227063e-07 | 6.652 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.203332e-07 | 6.494 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.560811e-07 | 6.255 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.232712e-06 | 5.909 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.717782e-06 | 5.765 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.727512e-06 | 5.763 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.894149e-06 | 5.538 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.361817e-06 | 5.078 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.993677e-05 | 4.700 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.211666e-05 | 4.493 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.443726e-05 | 4.463 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.809045e-05 | 4.419 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.765879e-05 | 4.424 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.737330e-05 | 4.427 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.129107e-05 | 4.384 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.713291e-05 | 4.327 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.713291e-05 | 4.327 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.368049e-05 | 4.196 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.855306e-05 | 4.164 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.360857e-05 | 4.078 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.493369e-05 | 4.071 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.988138e-05 | 4.001 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.240319e-04 | 3.906 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.332506e-04 | 3.875 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.430551e-04 | 3.844 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.971104e-04 | 3.705 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.395278e-04 | 3.621 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.494426e-04 | 3.603 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.494426e-04 | 3.603 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.707560e-04 | 3.567 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.846811e-04 | 3.546 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.621055e-04 | 3.441 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.892696e-04 | 3.410 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.892696e-04 | 3.410 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.892696e-04 | 3.410 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.892696e-04 | 3.410 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.618979e-04 | 3.335 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.824233e-04 | 3.317 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.824233e-04 | 3.317 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.942047e-04 | 3.306 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.060539e-04 | 3.296 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.704742e-04 | 3.244 | 1 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.294857e-04 | 3.276 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.052683e-04 | 3.218 | 1 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.174626e-04 | 3.209 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.090170e-04 | 3.149 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.577652e-04 | 3.067 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.210223e-04 | 3.036 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 9.210223e-04 | 3.036 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 9.939702e-04 | 3.003 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.030690e-03 | 2.987 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.159975e-03 | 2.936 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.110863e-03 | 2.954 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.180153e-03 | 2.928 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.226743e-03 | 2.911 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.353256e-03 | 2.869 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 1.353256e-03 | 2.869 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.542109e-03 | 2.812 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.417793e-03 | 2.848 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.694570e-03 | 2.771 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.694570e-03 | 2.771 | 1 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.855193e-03 | 2.732 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.994879e-03 | 2.700 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.117883e-03 | 2.674 | 1 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.273820e-03 | 2.643 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.249092e-03 | 2.648 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.137396e-03 | 2.670 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.615708e-03 | 2.582 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.912148e-03 | 2.536 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.128933e-03 | 2.505 | 1 | 1 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.128933e-03 | 2.505 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.128933e-03 | 2.505 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.128933e-03 | 2.505 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.592496e-03 | 2.445 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.264239e-03 | 2.370 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.497435e-03 | 2.347 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.591867e-03 | 2.338 | 1 | 1 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.848746e-03 | 2.314 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.072264e-03 | 2.295 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.228077e-03 | 2.282 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.353107e-03 | 2.271 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.919818e-03 | 2.228 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.282253e-03 | 2.202 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.424773e-03 | 2.129 | 1 | 1 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.424773e-03 | 2.129 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.408184e-03 | 2.193 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.408184e-03 | 2.193 | 1 | 1 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.424773e-03 | 2.129 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.468207e-03 | 2.189 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.455206e-03 | 2.128 | 1 | 1 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.455206e-03 | 2.128 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.613967e-03 | 2.118 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.124469e-03 | 2.090 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.597633e-03 | 2.066 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.597633e-03 | 2.066 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 8.653675e-03 | 2.063 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 1.136293e-02 | 1.945 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.136293e-02 | 1.945 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.050506e-02 | 1.979 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.188229e-02 | 1.925 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 9.967028e-03 | 2.001 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.253026e-02 | 1.902 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 1.261410e-02 | 1.899 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.439495e-02 | 1.842 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.439495e-02 | 1.842 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.439495e-02 | 1.842 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.519469e-02 | 1.818 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.579543e-02 | 1.801 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 1.602741e-02 | 1.795 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.773513e-02 | 1.751 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.788832e-02 | 1.747 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.845079e-02 | 1.734 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.951634e-02 | 1.710 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 2.329239e-02 | 1.633 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.035026e-02 | 1.691 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 2.483816e-02 | 1.605 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.133885e-02 | 1.671 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.101563e-02 | 1.677 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.329239e-02 | 1.633 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.407975e-02 | 1.618 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.136933e-02 | 1.670 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.136933e-02 | 1.670 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.528387e-02 | 1.597 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.652934e-02 | 1.576 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.665967e-02 | 1.574 | 1 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.667081e-02 | 1.574 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.688340e-02 | 1.571 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.688340e-02 | 1.571 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.688340e-02 | 1.571 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.884575e-02 | 1.540 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.946550e-02 | 1.531 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.135819e-02 | 1.504 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.135819e-02 | 1.504 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.135819e-02 | 1.504 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.140179e-02 | 1.503 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.621084e-02 | 1.441 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.854357e-02 | 1.414 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 3.857921e-02 | 1.414 | 1 | 1 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.857921e-02 | 1.414 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.926557e-02 | 1.406 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 4.159212e-02 | 1.381 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 4.159212e-02 | 1.381 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.171856e-02 | 1.286 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.171856e-02 | 1.286 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.171856e-02 | 1.286 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.100505e-02 | 1.387 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.348688e-02 | 1.362 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.394583e-02 | 1.268 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.097224e-02 | 1.388 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.125413e-02 | 1.290 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.394583e-02 | 1.268 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.159212e-02 | 1.381 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.066459e-02 | 1.391 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.348688e-02 | 1.362 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.602328e-02 | 1.337 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.377910e-02 | 1.269 | 1 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.100505e-02 | 1.387 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.602328e-02 | 1.337 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.947502e-02 | 1.226 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 5.947502e-02 | 1.226 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.947502e-02 | 1.226 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 6.173862e-02 | 1.209 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 6.173862e-02 | 1.209 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 6.173862e-02 | 1.209 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.173862e-02 | 1.209 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.173862e-02 | 1.209 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.230990e-02 | 1.205 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 6.447545e-02 | 1.191 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.781005e-02 | 1.169 | 1 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.811382e-02 | 1.167 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.811382e-02 | 1.167 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.815196e-02 | 1.167 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.815196e-02 | 1.167 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.108037e-02 | 1.148 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.108037e-02 | 1.148 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 7.165341e-02 | 1.145 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 7.165341e-02 | 1.145 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 7.165341e-02 | 1.145 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 7.165341e-02 | 1.145 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 7.165341e-02 | 1.145 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 8.146404e-02 | 1.089 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 8.146404e-02 | 1.089 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 8.146404e-02 | 1.089 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 8.146404e-02 | 1.089 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 9.117159e-02 | 1.040 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 7.943069e-02 | 1.100 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 7.943069e-02 | 1.100 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.408835e-02 | 1.130 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.713658e-02 | 1.113 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 8.146404e-02 | 1.089 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.651104e-02 | 1.063 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 8.146404e-02 | 1.089 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 8.146404e-02 | 1.089 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 8.146404e-02 | 1.089 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.970868e-02 | 1.047 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.970868e-02 | 1.047 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.007771e-01 | 0.997 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.651104e-02 | 1.063 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 8.146404e-02 | 1.089 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 1.007771e-01 | 0.997 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 9.117159e-02 | 1.040 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.028342e-01 | 0.988 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.095834e-01 | 0.960 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 8.146404e-02 | 1.089 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 8.146404e-02 | 1.089 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.538870e-02 | 1.123 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.713658e-02 | 1.113 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.713658e-02 | 1.113 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.022386e-02 | 1.096 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.336020e-02 | 1.079 | 1 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.466505e-02 | 1.127 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.030514e-01 | 0.987 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.030514e-01 | 0.987 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.620659e-02 | 1.017 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.282655e-02 | 1.082 | 1 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.061941e-01 | 0.974 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.102818e-01 | 0.957 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.102818e-01 | 0.957 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.102818e-01 | 0.957 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 1.102818e-01 | 0.957 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.102818e-01 | 0.957 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 1.102818e-01 | 0.957 | 1 | 1 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.102818e-01 | 0.957 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.119683e-01 | 0.951 | 1 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.119683e-01 | 0.951 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.382005e-01 | 0.859 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.382005e-01 | 0.859 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.382005e-01 | 0.859 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.382005e-01 | 0.859 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.473118e-01 | 0.832 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.563273e-01 | 0.806 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.563273e-01 | 0.806 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.563273e-01 | 0.806 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.563273e-01 | 0.806 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.563273e-01 | 0.806 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.740751e-01 | 0.759 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.828093e-01 | 0.738 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.828093e-01 | 0.738 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.828093e-01 | 0.738 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.828093e-01 | 0.738 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.914516e-01 | 0.718 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.084647e-01 | 0.681 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.251218e-01 | 0.648 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.084647e-01 | 0.681 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.084647e-01 | 0.681 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.168373e-01 | 0.664 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.485336e-01 | 0.828 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.168373e-01 | 0.664 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.652481e-01 | 0.782 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.168373e-01 | 0.664 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.586614e-01 | 0.800 | 1 | 1 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.196865e-01 | 0.922 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.563273e-01 | 0.806 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.652481e-01 | 0.782 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.828093e-01 | 0.738 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.876910e-01 | 0.727 | 1 | 1 |
| Processing of SMDT1 | R-HSA-8949664 | 1.652481e-01 | 0.782 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.153229e-01 | 0.938 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.000031e-01 | 0.699 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.251218e-01 | 0.648 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.289924e-01 | 0.889 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.382005e-01 | 0.859 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.473118e-01 | 0.832 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.473118e-01 | 0.832 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.563273e-01 | 0.806 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.828093e-01 | 0.738 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.251218e-01 | 0.648 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.234147e-01 | 0.909 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 2.084647e-01 | 0.681 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 1.708030e-01 | 0.768 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.376400e-01 | 0.861 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.898187e-01 | 0.722 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.225751e-01 | 0.912 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.740751e-01 | 0.759 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.251218e-01 | 0.648 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.522032e-01 | 0.818 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.740881e-01 | 0.759 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.563273e-01 | 0.806 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.652481e-01 | 0.782 | 1 | 1 |
| Signaling by Activin | R-HSA-1502540 | 1.828093e-01 | 0.738 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.563273e-01 | 0.806 | 1 | 1 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 1.563273e-01 | 0.806 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.289924e-01 | 0.889 | 1 | 1 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.563273e-01 | 0.806 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.363911e-01 | 0.865 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.089749e-01 | 0.680 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.115028e-01 | 0.675 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.859145e-01 | 0.731 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 1.382005e-01 | 0.859 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 1.828093e-01 | 0.738 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.084647e-01 | 0.681 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.005709e-01 | 0.698 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.206021e-01 | 0.656 | 1 | 1 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.196865e-01 | 0.922 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.473118e-01 | 0.832 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.084647e-01 | 0.681 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 2.206021e-01 | 0.656 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.511133e-01 | 0.821 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.268685e-01 | 0.897 | 1 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.196865e-01 | 0.922 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.828093e-01 | 0.738 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.828093e-01 | 0.738 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.828093e-01 | 0.738 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 2.251218e-01 | 0.648 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.130639e-01 | 0.947 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.485336e-01 | 0.828 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.494419e-01 | 0.826 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.225821e-01 | 0.653 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.251218e-01 | 0.648 | 1 | 1 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.563273e-01 | 0.806 | 1 | 1 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.563273e-01 | 0.806 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.168373e-01 | 0.664 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.382005e-01 | 0.859 | 1 | 1 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.450064e-01 | 0.839 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.196865e-01 | 0.922 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.740751e-01 | 0.759 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.699916e-01 | 0.770 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.168373e-01 | 0.664 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 1.522032e-01 | 0.818 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.199176e-01 | 0.921 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 1.488932e-01 | 0.827 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 1.488932e-01 | 0.827 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.168373e-01 | 0.664 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.236457e-01 | 0.650 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.708030e-01 | 0.768 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.089749e-01 | 0.680 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.485336e-01 | 0.828 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 1.633157e-01 | 0.787 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.382005e-01 | 0.859 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.745682e-01 | 0.758 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 2.051135e-01 | 0.688 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.340499e-01 | 0.873 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.130010e-01 | 0.947 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.931622e-01 | 0.714 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.821378e-01 | 0.740 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.244902e-01 | 0.649 | 1 | 1 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.283836e-01 | 0.641 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.309215e-01 | 0.637 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 2.322817e-01 | 0.634 | 1 | 1 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.322817e-01 | 0.634 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.333192e-01 | 0.632 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.333192e-01 | 0.632 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.333192e-01 | 0.632 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.333192e-01 | 0.632 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.333192e-01 | 0.632 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.333192e-01 | 0.632 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.333192e-01 | 0.632 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.361841e-01 | 0.627 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.361841e-01 | 0.627 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.365134e-01 | 0.626 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.400901e-01 | 0.620 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.414304e-01 | 0.617 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.414304e-01 | 0.617 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.449454e-01 | 0.611 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.469114e-01 | 0.607 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.494563e-01 | 0.603 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.494563e-01 | 0.603 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.494563e-01 | 0.603 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.494563e-01 | 0.603 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.573977e-01 | 0.589 | 1 | 1 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.573977e-01 | 0.589 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.573977e-01 | 0.589 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.573977e-01 | 0.589 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.652557e-01 | 0.576 | 1 | 1 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.652557e-01 | 0.576 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.652557e-01 | 0.576 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.652557e-01 | 0.576 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.652557e-01 | 0.576 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.652557e-01 | 0.576 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.652557e-01 | 0.576 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 2.674937e-01 | 0.573 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.674937e-01 | 0.573 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.730309e-01 | 0.564 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.730309e-01 | 0.564 | 1 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.807243e-01 | 0.552 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.807243e-01 | 0.552 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.807243e-01 | 0.552 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.807243e-01 | 0.552 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.870737e-01 | 0.542 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.877122e-01 | 0.541 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.883368e-01 | 0.540 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.883368e-01 | 0.540 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.883368e-01 | 0.540 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 2.883368e-01 | 0.540 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.909847e-01 | 0.536 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.918485e-01 | 0.535 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.934684e-01 | 0.532 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.958692e-01 | 0.529 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.958692e-01 | 0.529 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.958692e-01 | 0.529 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.958692e-01 | 0.529 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.958692e-01 | 0.529 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 2.958692e-01 | 0.529 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.958692e-01 | 0.529 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.958692e-01 | 0.529 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.987987e-01 | 0.525 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.992326e-01 | 0.524 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.033223e-01 | 0.518 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.033223e-01 | 0.518 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.033223e-01 | 0.518 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.033223e-01 | 0.518 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.033223e-01 | 0.518 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.033223e-01 | 0.518 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.050032e-01 | 0.516 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.106970e-01 | 0.508 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.106970e-01 | 0.508 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 3.143837e-01 | 0.503 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.143837e-01 | 0.503 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.179941e-01 | 0.498 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.179941e-01 | 0.498 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.182690e-01 | 0.497 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.252144e-01 | 0.488 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 3.252144e-01 | 0.488 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.252144e-01 | 0.488 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.323587e-01 | 0.478 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.323587e-01 | 0.478 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.339046e-01 | 0.476 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.376129e-01 | 0.472 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.376129e-01 | 0.472 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.394277e-01 | 0.469 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.394277e-01 | 0.469 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.394277e-01 | 0.469 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.394277e-01 | 0.469 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.419430e-01 | 0.466 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.453062e-01 | 0.462 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.453062e-01 | 0.462 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.464224e-01 | 0.460 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 3.464224e-01 | 0.460 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 3.464224e-01 | 0.460 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.517642e-01 | 0.454 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.533434e-01 | 0.452 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.567915e-01 | 0.448 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.567915e-01 | 0.448 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.601916e-01 | 0.443 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.601916e-01 | 0.443 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.669676e-01 | 0.435 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.669676e-01 | 0.435 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.669676e-01 | 0.435 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.669676e-01 | 0.435 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.736724e-01 | 0.428 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 3.736724e-01 | 0.428 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.868707e-01 | 0.412 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.868707e-01 | 0.412 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.868707e-01 | 0.412 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.868707e-01 | 0.412 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.868707e-01 | 0.412 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.868707e-01 | 0.412 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.870487e-01 | 0.412 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.899080e-01 | 0.409 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.933658e-01 | 0.405 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.933658e-01 | 0.405 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.933658e-01 | 0.405 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.933658e-01 | 0.405 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.933658e-01 | 0.405 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.933658e-01 | 0.405 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 3.982382e-01 | 0.400 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 3.982382e-01 | 0.400 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.997925e-01 | 0.398 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.056457e-01 | 0.392 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.061515e-01 | 0.391 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.061515e-01 | 0.391 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.061515e-01 | 0.391 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.061515e-01 | 0.391 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.061515e-01 | 0.391 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.061515e-01 | 0.391 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.061515e-01 | 0.391 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.061515e-01 | 0.391 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.124436e-01 | 0.385 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.124436e-01 | 0.385 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 4.124436e-01 | 0.385 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.130096e-01 | 0.384 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.186693e-01 | 0.378 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.186693e-01 | 0.378 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.203286e-01 | 0.376 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.247974e-01 | 0.372 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.248295e-01 | 0.372 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 4.248295e-01 | 0.372 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.248295e-01 | 0.372 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.248295e-01 | 0.372 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.282104e-01 | 0.368 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.309248e-01 | 0.366 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.309248e-01 | 0.366 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.309248e-01 | 0.366 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 4.309248e-01 | 0.366 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.312197e-01 | 0.365 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.369558e-01 | 0.360 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.369558e-01 | 0.360 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.369558e-01 | 0.360 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.369558e-01 | 0.360 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.369558e-01 | 0.360 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.369558e-01 | 0.360 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.429233e-01 | 0.354 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.476948e-01 | 0.349 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.488279e-01 | 0.348 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.546703e-01 | 0.342 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.546703e-01 | 0.342 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 4.546703e-01 | 0.342 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.586221e-01 | 0.339 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.587114e-01 | 0.338 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.604511e-01 | 0.337 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.604511e-01 | 0.337 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 4.604511e-01 | 0.337 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.614513e-01 | 0.336 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.632266e-01 | 0.334 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.641853e-01 | 0.333 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 4.666316e-01 | 0.331 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.692371e-01 | 0.329 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.718307e-01 | 0.326 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.718307e-01 | 0.326 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.774306e-01 | 0.321 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.829715e-01 | 0.316 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.839742e-01 | 0.315 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.884541e-01 | 0.311 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.884541e-01 | 0.311 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 4.884541e-01 | 0.311 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.884541e-01 | 0.311 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.885129e-01 | 0.311 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.938788e-01 | 0.306 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.938788e-01 | 0.306 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.938788e-01 | 0.306 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.938788e-01 | 0.306 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 4.992463e-01 | 0.302 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.045572e-01 | 0.297 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.075476e-01 | 0.295 | 1 | 1 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.098121e-01 | 0.293 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.141541e-01 | 0.289 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 5.149075e-01 | 0.288 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.150117e-01 | 0.288 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.150117e-01 | 0.288 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 5.150117e-01 | 0.288 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 5.150117e-01 | 0.288 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.201563e-01 | 0.284 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.201563e-01 | 0.284 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.201563e-01 | 0.284 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.252468e-01 | 0.280 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.252468e-01 | 0.280 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.252468e-01 | 0.280 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.252468e-01 | 0.280 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.302835e-01 | 0.275 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.302835e-01 | 0.275 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.304145e-01 | 0.275 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.336222e-01 | 0.273 | 1 | 1 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.352671e-01 | 0.271 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.368151e-01 | 0.270 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.401981e-01 | 0.267 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.431560e-01 | 0.265 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.450772e-01 | 0.264 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.499047e-01 | 0.260 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.506157e-01 | 0.259 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.546813e-01 | 0.256 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.546813e-01 | 0.256 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.640839e-01 | 0.249 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.640839e-01 | 0.249 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.640839e-01 | 0.249 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.640839e-01 | 0.249 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 5.640839e-01 | 0.249 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.687109e-01 | 0.245 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.687109e-01 | 0.245 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.732890e-01 | 0.242 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.778189e-01 | 0.238 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.799717e-01 | 0.237 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.823009e-01 | 0.235 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.842297e-01 | 0.233 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.867357e-01 | 0.232 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.911236e-01 | 0.228 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.997610e-01 | 0.222 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.997610e-01 | 0.222 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.997610e-01 | 0.222 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.060677e-01 | 0.217 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.060677e-01 | 0.217 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.082169e-01 | 0.216 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.117071e-01 | 0.213 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.123781e-01 | 0.213 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.123781e-01 | 0.213 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.164953e-01 | 0.210 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 6.200512e-01 | 0.208 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.205690e-01 | 0.207 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.220874e-01 | 0.206 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.228019e-01 | 0.206 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.239302e-01 | 0.205 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.255374e-01 | 0.204 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.285878e-01 | 0.202 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.325338e-01 | 0.199 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.364381e-01 | 0.196 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.364381e-01 | 0.196 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.403012e-01 | 0.194 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 6.416298e-01 | 0.193 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 6.521575e-01 | 0.186 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.626375e-01 | 0.179 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.626375e-01 | 0.179 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.626375e-01 | 0.179 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.672402e-01 | 0.176 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.672402e-01 | 0.176 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.697721e-01 | 0.174 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.697721e-01 | 0.174 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.732829e-01 | 0.172 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.767567e-01 | 0.170 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 6.794855e-01 | 0.168 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.801937e-01 | 0.167 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.902883e-01 | 0.161 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.968413e-01 | 0.157 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.000660e-01 | 0.155 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.000660e-01 | 0.155 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.021360e-01 | 0.154 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.064134e-01 | 0.151 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 7.196982e-01 | 0.143 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.217036e-01 | 0.142 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.217036e-01 | 0.142 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.217036e-01 | 0.142 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.233831e-01 | 0.141 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.333636e-01 | 0.135 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.333636e-01 | 0.135 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.333636e-01 | 0.135 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.373582e-01 | 0.132 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 7.397726e-01 | 0.131 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.414211e-01 | 0.130 | 1 | 0 |
| Transport of small molecules | R-HSA-382551 | 7.427934e-01 | 0.129 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 7.443121e-01 | 0.128 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.499491e-01 | 0.125 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.499491e-01 | 0.125 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.500899e-01 | 0.125 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.526118e-01 | 0.123 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.611820e-01 | 0.119 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 7.680065e-01 | 0.115 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.704781e-01 | 0.113 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.801051e-01 | 0.108 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.826813e-01 | 0.106 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.836781e-01 | 0.106 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 7.902797e-01 | 0.102 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 7.915763e-01 | 0.102 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.915763e-01 | 0.102 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.923410e-01 | 0.101 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.937981e-01 | 0.100 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.959964e-01 | 0.099 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.045589e-01 | 0.094 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.050606e-01 | 0.094 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.107454e-01 | 0.091 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.186923e-01 | 0.087 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 8.193862e-01 | 0.087 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.263073e-01 | 0.083 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.281609e-01 | 0.082 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.351612e-01 | 0.078 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 8.371377e-01 | 0.077 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.371377e-01 | 0.077 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.420087e-01 | 0.075 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.422984e-01 | 0.075 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.456482e-01 | 0.073 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.456482e-01 | 0.073 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.489273e-01 | 0.071 | 1 | 1 |
| Signaling by WNT | R-HSA-195721 | 8.532337e-01 | 0.069 | 0 | 0 |
| Translation | R-HSA-72766 | 8.591759e-01 | 0.066 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.613653e-01 | 0.065 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.636413e-01 | 0.064 | 1 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.671970e-01 | 0.062 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.671970e-01 | 0.062 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.700207e-01 | 0.060 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.801583e-01 | 0.055 | 1 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 8.821174e-01 | 0.054 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.845172e-01 | 0.053 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.905637e-01 | 0.050 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.917347e-01 | 0.050 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.928932e-01 | 0.049 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.038216e-01 | 0.044 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.038216e-01 | 0.044 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.048736e-01 | 0.043 | 1 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.058704e-01 | 0.043 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.068785e-01 | 0.042 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.068785e-01 | 0.042 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.108046e-01 | 0.041 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.216225e-01 | 0.035 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.241165e-01 | 0.034 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.303883e-01 | 0.031 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.311351e-01 | 0.031 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.326049e-01 | 0.030 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.340435e-01 | 0.030 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.375079e-01 | 0.028 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.381788e-01 | 0.028 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.426785e-01 | 0.026 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.426799e-01 | 0.026 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.433835e-01 | 0.025 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.439032e-01 | 0.025 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.589747e-01 | 0.018 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.676434e-01 | 0.014 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.748203e-01 | 0.011 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.769143e-01 | 0.010 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.838713e-01 | 0.007 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.888624e-01 | 0.005 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.915213e-01 | 0.004 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.919719e-01 | 0.004 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.925046e-01 | 0.003 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.949142e-01 | 0.002 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.971958e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.978341e-01 | 0.001 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.998909e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999998e-01 | 0.000 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.000000e+00 | 0.000 | 1 | 1 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 1.000000e+00 | 0.000 | 1 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.000000e+00 | 0.000 | 1 | 1 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.000000e+00 | 0.000 | 1 | 1 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.000000e+00 | 0.000 | 1 | 1 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.332268e-14 | 13.875 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.964295e-14 | 13.528 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.248957e-14 | 13.084 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.248957e-14 | 13.084 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.547651e-13 | 12.810 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.725908e-13 | 12.429 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.914957e-13 | 12.308 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.372192e-13 | 12.077 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.372192e-13 | 12.077 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.389333e-12 | 11.857 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.490141e-12 | 11.827 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.773581e-12 | 11.751 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.773581e-12 | 11.751 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.981526e-12 | 11.703 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.981526e-12 | 11.703 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.251310e-12 | 11.648 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.685296e-12 | 11.571 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.569589e-12 | 11.447 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.569589e-12 | 11.447 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.460765e-12 | 11.351 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.460765e-12 | 11.351 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.868506e-12 | 11.163 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.868506e-12 | 11.163 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.990941e-12 | 11.097 | 1 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.466006e-12 | 11.072 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.303558e-12 | 11.031 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.270228e-11 | 10.896 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.270228e-11 | 10.896 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.244793e-11 | 10.905 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.294642e-11 | 10.888 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.546663e-11 | 10.811 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.267619e-11 | 10.644 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.613321e-11 | 10.442 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.922207e-11 | 10.406 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.207745e-11 | 10.376 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.677803e-11 | 10.330 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.844691e-11 | 10.315 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.110135e-11 | 10.292 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.561918e-11 | 10.255 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.891176e-11 | 10.230 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.355649e-11 | 10.197 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.593626e-11 | 10.181 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.794365e-11 | 10.108 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.266703e-10 | 9.897 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.481609e-10 | 9.829 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.728733e-10 | 9.762 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.219128e-10 | 9.654 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.336935e-10 | 9.631 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.159053e-10 | 9.381 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.253028e-10 | 9.371 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.779019e-10 | 9.321 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.944353e-10 | 9.306 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.480673e-10 | 9.261 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.167438e-10 | 9.145 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.030238e-10 | 9.153 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.167438e-10 | 9.145 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.174117e-10 | 9.088 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.505580e-09 | 8.822 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.505580e-09 | 8.822 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.537140e-09 | 8.813 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.505580e-09 | 8.822 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.956878e-09 | 8.708 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.071503e-09 | 8.684 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.476453e-09 | 8.606 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.779910e-09 | 8.556 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.779910e-09 | 8.556 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.787148e-09 | 8.555 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.900020e-09 | 8.409 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.354450e-09 | 8.361 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.531082e-09 | 8.344 | 1 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.221097e-09 | 8.085 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.295434e-09 | 8.081 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.102551e-09 | 8.041 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.170374e-08 | 7.932 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.227536e-08 | 7.911 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.504224e-08 | 7.823 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.794719e-08 | 7.746 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.886705e-08 | 7.724 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.979656e-08 | 7.703 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.915903e-08 | 7.535 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.118146e-08 | 7.506 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.052612e-08 | 7.392 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.052612e-08 | 7.392 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.871128e-08 | 7.412 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 5.149243e-08 | 7.288 | 1 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.172247e-08 | 7.210 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.525131e-08 | 7.069 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 9.225474e-08 | 7.035 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.065076e-07 | 6.973 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.142106e-07 | 6.942 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.256962e-07 | 6.901 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.460690e-07 | 6.835 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.822146e-07 | 6.739 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.105148e-07 | 6.677 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.420277e-07 | 6.616 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.602751e-07 | 6.585 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.602751e-07 | 6.585 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.602751e-07 | 6.585 | 0 | 0 |
| Disease | R-HSA-1643685 | 3.420721e-07 | 6.466 | 1 | 0 |
| Reproduction | R-HSA-1474165 | 3.919610e-07 | 6.407 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.024903e-07 | 6.395 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.115786e-07 | 6.386 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.939469e-07 | 6.306 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.608040e-07 | 6.251 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.981040e-07 | 6.223 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.751791e-07 | 6.171 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 6.809749e-07 | 6.167 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.125364e-06 | 5.949 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.172257e-06 | 5.931 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.366639e-06 | 5.864 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.794388e-06 | 5.746 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.794388e-06 | 5.746 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.896693e-06 | 5.722 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.931761e-06 | 5.714 | 1 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.235000e-06 | 5.651 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.310700e-06 | 5.636 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.443378e-06 | 5.612 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.657645e-06 | 5.576 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.664544e-06 | 5.574 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.155210e-06 | 5.381 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.813940e-06 | 5.317 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.053093e-06 | 5.296 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.345777e-06 | 5.272 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.411624e-06 | 5.267 | 1 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.584792e-06 | 5.253 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.047050e-06 | 5.152 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 9.847495e-06 | 5.007 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 9.847495e-06 | 5.007 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 9.847495e-06 | 5.007 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.282615e-05 | 4.892 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.357669e-05 | 4.867 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.788924e-05 | 4.747 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.275698e-05 | 4.643 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.372016e-05 | 4.625 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.654062e-05 | 4.576 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.658225e-05 | 4.575 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.730834e-05 | 4.564 | 1 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.861821e-05 | 4.543 | 1 | 1 |
| Deubiquitination | R-HSA-5688426 | 2.933639e-05 | 4.533 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.346982e-05 | 4.475 | 1 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.023907e-05 | 4.395 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.843223e-05 | 4.315 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.055915e-05 | 4.296 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.109133e-05 | 4.292 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.800722e-05 | 4.237 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.584026e-05 | 4.182 | 1 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.019772e-05 | 4.154 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.962039e-05 | 4.099 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.873223e-05 | 4.052 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.160584e-04 | 3.935 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.873220e-05 | 4.006 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.088365e-04 | 3.963 | 1 | 0 |
| Apoptosis | R-HSA-109581 | 1.089705e-04 | 3.963 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.178627e-04 | 3.929 | 1 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.182100e-04 | 3.927 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.516941e-04 | 3.819 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.603920e-04 | 3.795 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.623560e-04 | 3.790 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.623560e-04 | 3.790 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.896021e-04 | 3.722 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.118945e-04 | 3.674 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.132499e-04 | 3.671 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.234764e-04 | 3.651 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.302157e-04 | 3.638 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.420549e-04 | 3.616 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.533772e-04 | 3.596 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.533772e-04 | 3.596 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.533772e-04 | 3.596 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.533772e-04 | 3.596 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.730523e-04 | 3.564 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.989980e-04 | 3.524 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.631987e-04 | 3.440 | 1 | 1 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.634411e-04 | 3.440 | 1 | 1 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.942340e-04 | 3.404 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.946464e-04 | 3.404 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.201503e-04 | 3.377 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.207805e-04 | 3.376 | 1 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.402649e-04 | 3.356 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.515116e-04 | 3.345 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.546766e-04 | 3.342 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.915735e-04 | 3.308 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.152486e-04 | 3.288 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.615812e-04 | 3.251 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.707510e-04 | 3.244 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.343705e-04 | 3.134 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.500216e-04 | 3.125 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.372361e-04 | 3.196 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.349005e-04 | 3.134 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.811145e-04 | 3.107 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.043539e-04 | 3.219 | 1 | 1 |
| Developmental Biology | R-HSA-1266738 | 6.912696e-04 | 3.160 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.908475e-04 | 3.050 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.026730e-03 | 2.989 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.028794e-03 | 2.988 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.046228e-03 | 2.980 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.191050e-03 | 2.924 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.246215e-03 | 2.904 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.303572e-03 | 2.885 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.307569e-03 | 2.884 | 1 | 0 |
| Nervous system development | R-HSA-9675108 | 1.375747e-03 | 2.861 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.385155e-03 | 2.859 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.386021e-03 | 2.858 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.464090e-03 | 2.834 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.486697e-03 | 2.828 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.486697e-03 | 2.828 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.561917e-03 | 2.806 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.606969e-03 | 2.794 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.654533e-03 | 2.781 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.687726e-03 | 2.773 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.771539e-03 | 2.752 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.241538e-03 | 2.649 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.244325e-03 | 2.649 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.254995e-03 | 2.647 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.307463e-03 | 2.637 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.396173e-03 | 2.620 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.410191e-03 | 2.618 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.562356e-03 | 2.591 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.782163e-03 | 2.556 | 1 | 1 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.079996e-03 | 2.511 | 1 | 1 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.079996e-03 | 2.511 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 3.127088e-03 | 2.505 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.672353e-03 | 2.435 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.699595e-03 | 2.432 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.789200e-03 | 2.421 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.931444e-03 | 2.405 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.948681e-03 | 2.404 | 1 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.088135e-03 | 2.388 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.821436e-03 | 2.317 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.821436e-03 | 2.317 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.859211e-03 | 2.313 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.712395e-03 | 2.243 | 1 | 1 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.795268e-03 | 2.237 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.795268e-03 | 2.237 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 5.795268e-03 | 2.237 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.907242e-03 | 2.229 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.265285e-03 | 2.203 | 1 | 1 |
| Signaling by Interleukins | R-HSA-449147 | 6.627612e-03 | 2.179 | 1 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.851169e-03 | 2.164 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.931945e-03 | 2.101 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.987397e-03 | 2.098 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.375126e-03 | 2.028 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 9.202236e-03 | 2.036 | 1 | 1 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.440735e-03 | 2.025 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.987397e-03 | 2.098 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.375126e-03 | 2.028 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.987397e-03 | 2.098 | 1 | 1 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.851169e-03 | 2.164 | 1 | 1 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.987397e-03 | 2.098 | 1 | 1 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.987397e-03 | 2.098 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.851169e-03 | 2.164 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.013026e-02 | 1.994 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.931945e-03 | 2.101 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.910959e-03 | 2.160 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.421314e-03 | 2.026 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.013306e-02 | 1.994 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.013306e-02 | 1.994 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.013306e-02 | 1.994 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.013306e-02 | 1.994 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.013306e-02 | 1.994 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.013306e-02 | 1.994 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.075855e-02 | 1.968 | 1 | 1 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.100194e-02 | 1.959 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.150761e-02 | 1.939 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.186101e-02 | 1.926 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.186101e-02 | 1.926 | 1 | 1 |
| Sensory processing of sound | R-HSA-9659379 | 1.250772e-02 | 1.903 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.266431e-02 | 1.897 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.330165e-02 | 1.876 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.330165e-02 | 1.876 | 1 | 1 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.330165e-02 | 1.876 | 1 | 1 |
| FLT3 Signaling | R-HSA-9607240 | 1.339147e-02 | 1.873 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.481429e-02 | 1.829 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.485332e-02 | 1.828 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.491600e-02 | 1.826 | 1 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.601923e-02 | 1.795 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.653472e-02 | 1.782 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.794515e-02 | 1.746 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.804926e-02 | 1.744 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.914053e-02 | 1.718 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.976848e-02 | 1.704 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.016407e-02 | 1.695 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.099671e-02 | 1.678 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.155350e-02 | 1.666 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.172498e-02 | 1.663 | 1 | 1 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.294828e-02 | 1.639 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.297962e-02 | 1.639 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.297962e-02 | 1.639 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.297962e-02 | 1.639 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.340282e-02 | 1.631 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.524533e-02 | 1.598 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.531498e-02 | 1.597 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.531498e-02 | 1.597 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.531498e-02 | 1.597 | 1 | 1 |
| Signal transduction by L1 | R-HSA-445144 | 2.728852e-02 | 1.564 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.824434e-02 | 1.549 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.833735e-02 | 1.548 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.913883e-02 | 1.536 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.916263e-02 | 1.535 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.932202e-02 | 1.533 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.937488e-02 | 1.532 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.009404e-02 | 1.522 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 3.009404e-02 | 1.522 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.141409e-02 | 1.503 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.290773e-02 | 1.483 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.295476e-02 | 1.482 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.356333e-02 | 1.474 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.356333e-02 | 1.474 | 1 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.512499e-02 | 1.454 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.538161e-02 | 1.451 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 3.576840e-02 | 1.447 | 1 | 1 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.576840e-02 | 1.447 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.576840e-02 | 1.447 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.665330e-02 | 1.436 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.665330e-02 | 1.436 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 3.802795e-02 | 1.420 | 1 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.802795e-02 | 1.420 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.802795e-02 | 1.420 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.802795e-02 | 1.420 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.992398e-02 | 1.399 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 3.992398e-02 | 1.399 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 3.992398e-02 | 1.399 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 3.992398e-02 | 1.399 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.992398e-02 | 1.399 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 3.992398e-02 | 1.399 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.992398e-02 | 1.399 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.992398e-02 | 1.399 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.992398e-02 | 1.399 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.992398e-02 | 1.399 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.992398e-02 | 1.399 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.992398e-02 | 1.399 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.992398e-02 | 1.399 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.992398e-02 | 1.399 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.992398e-02 | 1.399 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.992398e-02 | 1.399 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.034068e-02 | 1.394 | 1 | 1 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.270527e-02 | 1.370 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.965490e-02 | 1.304 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.965490e-02 | 1.304 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.965490e-02 | 1.304 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.965490e-02 | 1.304 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.928778e-02 | 1.227 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.928778e-02 | 1.227 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 6.882362e-02 | 1.162 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.826337e-02 | 1.106 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.826337e-02 | 1.106 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 7.826337e-02 | 1.106 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 8.760801e-02 | 1.057 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 8.760801e-02 | 1.057 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.334074e-02 | 1.198 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.526246e-02 | 1.258 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.611722e-02 | 1.180 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.357886e-02 | 1.078 | 1 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.611722e-02 | 1.180 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.882362e-02 | 1.162 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.826337e-02 | 1.106 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.009766e-02 | 1.300 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.265721e-02 | 1.279 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.265721e-02 | 1.279 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.965490e-02 | 1.304 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.512047e-02 | 1.346 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.178910e-02 | 1.144 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.761243e-02 | 1.110 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.661322e-02 | 1.062 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.928778e-02 | 1.227 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.057827e-02 | 1.094 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.825363e-02 | 1.235 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.928778e-02 | 1.227 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.697418e-02 | 1.174 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.826337e-02 | 1.106 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.826337e-02 | 1.106 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 8.760801e-02 | 1.057 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.526246e-02 | 1.258 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.913321e-02 | 1.309 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.369815e-02 | 1.270 | 1 | 1 |
| Elastic fibre formation | R-HSA-1566948 | 7.761243e-02 | 1.110 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 4.913321e-02 | 1.309 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.215448e-02 | 1.283 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.042149e-02 | 1.219 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.174106e-02 | 1.209 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.512047e-02 | 1.346 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.791223e-02 | 1.237 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.057827e-02 | 1.094 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.874202e-02 | 1.052 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.874202e-02 | 1.052 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.968035e-02 | 1.047 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.277929e-02 | 1.033 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.590910e-02 | 1.018 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.590910e-02 | 1.018 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 9.685848e-02 | 1.014 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 9.685848e-02 | 1.014 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 9.685848e-02 | 1.014 | 1 | 1 |
| SOS-mediated signalling | R-HSA-112412 | 9.685848e-02 | 1.014 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 9.685848e-02 | 1.014 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 9.685848e-02 | 1.014 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.906883e-02 | 1.004 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.000328e-01 | 1.000 | 1 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.010113e-01 | 0.996 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.030840e-01 | 0.987 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.054744e-01 | 0.977 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.060157e-01 | 0.975 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.060157e-01 | 0.975 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 1.060157e-01 | 0.975 | 1 | 1 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.060157e-01 | 0.975 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.119889e-01 | 0.951 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.136966e-01 | 0.944 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.150807e-01 | 0.939 | 1 | 1 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.150807e-01 | 0.939 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.150807e-01 | 0.939 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.150807e-01 | 0.939 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.150807e-01 | 0.939 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.150807e-01 | 0.939 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.150807e-01 | 0.939 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.202939e-01 | 0.920 | 1 | 0 |
| Hemostasis | R-HSA-109582 | 1.211811e-01 | 0.917 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.240543e-01 | 0.906 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.240543e-01 | 0.906 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.240543e-01 | 0.906 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.240543e-01 | 0.906 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.240543e-01 | 0.906 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.240543e-01 | 0.906 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.253170e-01 | 0.902 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.329374e-01 | 0.876 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.329374e-01 | 0.876 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.329374e-01 | 0.876 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 1.329374e-01 | 0.876 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.329374e-01 | 0.876 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 1.329374e-01 | 0.876 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.384000e-01 | 0.859 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.390005e-01 | 0.857 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.417310e-01 | 0.849 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.447569e-01 | 0.839 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.504360e-01 | 0.823 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.504360e-01 | 0.823 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.504360e-01 | 0.823 | 1 | 1 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.504360e-01 | 0.823 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.504360e-01 | 0.823 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.504360e-01 | 0.823 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.504360e-01 | 0.823 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.504360e-01 | 0.823 | 1 | 1 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.504360e-01 | 0.823 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.504360e-01 | 0.823 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.504360e-01 | 0.823 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.529902e-01 | 0.815 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.565301e-01 | 0.805 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.590532e-01 | 0.798 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.590532e-01 | 0.798 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.590532e-01 | 0.798 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.590532e-01 | 0.798 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.590532e-01 | 0.798 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.600855e-01 | 0.796 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.647335e-01 | 0.783 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.672403e-01 | 0.777 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.672403e-01 | 0.777 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.675835e-01 | 0.776 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.675835e-01 | 0.776 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.675835e-01 | 0.776 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.675835e-01 | 0.776 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.708385e-01 | 0.767 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.760279e-01 | 0.754 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.760279e-01 | 0.754 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.760279e-01 | 0.754 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.760279e-01 | 0.754 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.760279e-01 | 0.754 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.760279e-01 | 0.754 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 1.760279e-01 | 0.754 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.760279e-01 | 0.754 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.760279e-01 | 0.754 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.760279e-01 | 0.754 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.760279e-01 | 0.754 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 1.843870e-01 | 0.734 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.843870e-01 | 0.734 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.843870e-01 | 0.734 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.843870e-01 | 0.734 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.843870e-01 | 0.734 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.926619e-01 | 0.715 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.926619e-01 | 0.715 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 1.926619e-01 | 0.715 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 1.926777e-01 | 0.715 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.000385e-01 | 0.699 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.000385e-01 | 0.699 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.008534e-01 | 0.697 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.008534e-01 | 0.697 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.008534e-01 | 0.697 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.008534e-01 | 0.697 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.089622e-01 | 0.680 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.089622e-01 | 0.680 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.163523e-01 | 0.665 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.169892e-01 | 0.664 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.169892e-01 | 0.664 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.185756e-01 | 0.660 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 2.185756e-01 | 0.660 | 1 | 1 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.249353e-01 | 0.648 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.260335e-01 | 0.646 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.260335e-01 | 0.646 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.328012e-01 | 0.633 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.328012e-01 | 0.633 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.328012e-01 | 0.633 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.328012e-01 | 0.633 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.328012e-01 | 0.633 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.335100e-01 | 0.632 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.405878e-01 | 0.619 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.405878e-01 | 0.619 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.405878e-01 | 0.619 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 2.405878e-01 | 0.619 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.482959e-01 | 0.605 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.482959e-01 | 0.605 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.485041e-01 | 0.605 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.485041e-01 | 0.605 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.485041e-01 | 0.605 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.485041e-01 | 0.605 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.559261e-01 | 0.592 | 1 | 1 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.559261e-01 | 0.592 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.559261e-01 | 0.592 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.559261e-01 | 0.592 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.559261e-01 | 0.592 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.559261e-01 | 0.592 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.561302e-01 | 0.592 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.615835e-01 | 0.582 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.634794e-01 | 0.579 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 2.634794e-01 | 0.579 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.634794e-01 | 0.579 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 2.638048e-01 | 0.579 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.709565e-01 | 0.567 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.709565e-01 | 0.567 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.709565e-01 | 0.567 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.709565e-01 | 0.567 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.783581e-01 | 0.555 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 2.783581e-01 | 0.555 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.785602e-01 | 0.555 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.785602e-01 | 0.555 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 2.785602e-01 | 0.555 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.856850e-01 | 0.544 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.856850e-01 | 0.544 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.856850e-01 | 0.544 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.856850e-01 | 0.544 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 2.856850e-01 | 0.544 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 2.898218e-01 | 0.538 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.898218e-01 | 0.538 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.929380e-01 | 0.533 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.929380e-01 | 0.533 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.929380e-01 | 0.533 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 2.929380e-01 | 0.533 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.929380e-01 | 0.533 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.001178e-01 | 0.523 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.001178e-01 | 0.523 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.010632e-01 | 0.521 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.048043e-01 | 0.516 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.072251e-01 | 0.513 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.072251e-01 | 0.513 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.072251e-01 | 0.513 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.072251e-01 | 0.513 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 3.072251e-01 | 0.513 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.122754e-01 | 0.505 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.142607e-01 | 0.503 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.142607e-01 | 0.503 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.142607e-01 | 0.503 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.142607e-01 | 0.503 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.212253e-01 | 0.493 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.261552e-01 | 0.487 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.281195e-01 | 0.484 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.281195e-01 | 0.484 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.281195e-01 | 0.484 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.281195e-01 | 0.484 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.281195e-01 | 0.484 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.349442e-01 | 0.475 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.349442e-01 | 0.475 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.349442e-01 | 0.475 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 3.416999e-01 | 0.466 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.416999e-01 | 0.466 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.483875e-01 | 0.458 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.493344e-01 | 0.457 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.550075e-01 | 0.450 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.550075e-01 | 0.450 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 3.569365e-01 | 0.447 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.615606e-01 | 0.442 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.615606e-01 | 0.442 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 3.680476e-01 | 0.434 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.680476e-01 | 0.434 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.680476e-01 | 0.434 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.712566e-01 | 0.430 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.744691e-01 | 0.427 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.744691e-01 | 0.427 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.744691e-01 | 0.427 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.744691e-01 | 0.427 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.808257e-01 | 0.419 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.808257e-01 | 0.419 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.808257e-01 | 0.419 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.808257e-01 | 0.419 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.808257e-01 | 0.419 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.808257e-01 | 0.419 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.808257e-01 | 0.419 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.808257e-01 | 0.419 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.808257e-01 | 0.419 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.857099e-01 | 0.414 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.871181e-01 | 0.412 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.871181e-01 | 0.412 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.995129e-01 | 0.398 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.000190e-01 | 0.398 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 4.000190e-01 | 0.398 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 4.017224e-01 | 0.396 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 4.078719e-01 | 0.389 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.106491e-01 | 0.387 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.116585e-01 | 0.385 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.116585e-01 | 0.385 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.116585e-01 | 0.385 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.116585e-01 | 0.385 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.116585e-01 | 0.385 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.176394e-01 | 0.379 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.176394e-01 | 0.379 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.235599e-01 | 0.373 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.235599e-01 | 0.373 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.235599e-01 | 0.373 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.235599e-01 | 0.373 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.235599e-01 | 0.373 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.235599e-01 | 0.373 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.294205e-01 | 0.367 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.352220e-01 | 0.361 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.352220e-01 | 0.361 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 4.352220e-01 | 0.361 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.409648e-01 | 0.356 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.409648e-01 | 0.356 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.409648e-01 | 0.356 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.466495e-01 | 0.350 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.466495e-01 | 0.350 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.522768e-01 | 0.345 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 4.522768e-01 | 0.345 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.578473e-01 | 0.339 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.578473e-01 | 0.339 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.611891e-01 | 0.336 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.633614e-01 | 0.334 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.688197e-01 | 0.329 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.690355e-01 | 0.329 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.742229e-01 | 0.324 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.795715e-01 | 0.319 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.795715e-01 | 0.319 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 4.845996e-01 | 0.315 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.848659e-01 | 0.314 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 4.848659e-01 | 0.314 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.848659e-01 | 0.314 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.855526e-01 | 0.314 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 4.871714e-01 | 0.312 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.901069e-01 | 0.310 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.952948e-01 | 0.305 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.952948e-01 | 0.305 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.017500e-01 | 0.300 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.055138e-01 | 0.296 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.055138e-01 | 0.296 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.105459e-01 | 0.292 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.105459e-01 | 0.292 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.105459e-01 | 0.292 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.113111e-01 | 0.291 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 5.155271e-01 | 0.288 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.155271e-01 | 0.288 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.204580e-01 | 0.284 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.269786e-01 | 0.278 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.331508e-01 | 0.273 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.349532e-01 | 0.272 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.396875e-01 | 0.268 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 5.396875e-01 | 0.268 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.396875e-01 | 0.268 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.423062e-01 | 0.266 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.490128e-01 | 0.260 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.490128e-01 | 0.260 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.490128e-01 | 0.260 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 5.536048e-01 | 0.257 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.543200e-01 | 0.256 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.581503e-01 | 0.253 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.671039e-01 | 0.246 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.671039e-01 | 0.246 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.758770e-01 | 0.240 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 5.833766e-01 | 0.234 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 5.833766e-01 | 0.234 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.844735e-01 | 0.233 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.844735e-01 | 0.233 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.844735e-01 | 0.233 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.890191e-01 | 0.230 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 5.980721e-01 | 0.223 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.092374e-01 | 0.215 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.132197e-01 | 0.212 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.210636e-01 | 0.207 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.249260e-01 | 0.204 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.249260e-01 | 0.204 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.249260e-01 | 0.204 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.287494e-01 | 0.202 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.287494e-01 | 0.202 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.472927e-01 | 0.189 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.508893e-01 | 0.186 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.508893e-01 | 0.186 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.544496e-01 | 0.184 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.544496e-01 | 0.184 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.547959e-01 | 0.184 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.596807e-01 | 0.181 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.614621e-01 | 0.179 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 6.649151e-01 | 0.177 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.649151e-01 | 0.177 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.649151e-01 | 0.177 | 0 | 0 |
| Translation | R-HSA-72766 | 6.751942e-01 | 0.171 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.783807e-01 | 0.169 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.849104e-01 | 0.164 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 6.881257e-01 | 0.162 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.913084e-01 | 0.160 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.945755e-01 | 0.158 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.967942e-01 | 0.157 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.975772e-01 | 0.156 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.067439e-01 | 0.151 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.067439e-01 | 0.151 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.127011e-01 | 0.147 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.185380e-01 | 0.144 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.185380e-01 | 0.144 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 7.223961e-01 | 0.141 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.326196e-01 | 0.135 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.326196e-01 | 0.135 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.353508e-01 | 0.134 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.353508e-01 | 0.134 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 7.380542e-01 | 0.132 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.562249e-01 | 0.121 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.611825e-01 | 0.119 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.636235e-01 | 0.117 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.800305e-01 | 0.108 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.800305e-01 | 0.108 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.910518e-01 | 0.102 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.933529e-01 | 0.101 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 7.953050e-01 | 0.099 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.015241e-01 | 0.096 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.134043e-01 | 0.090 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.172052e-01 | 0.088 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.209291e-01 | 0.086 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.263740e-01 | 0.083 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.350856e-01 | 0.078 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.367750e-01 | 0.077 | 1 | 1 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.384473e-01 | 0.077 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.496858e-01 | 0.071 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.557553e-01 | 0.068 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.557553e-01 | 0.068 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.572342e-01 | 0.067 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.572342e-01 | 0.067 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.671730e-01 | 0.062 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.801897e-01 | 0.055 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.844422e-01 | 0.053 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.973751e-01 | 0.047 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.015284e-01 | 0.045 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.074472e-01 | 0.042 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.130122e-01 | 0.040 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.247374e-01 | 0.034 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.339394e-01 | 0.030 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.355613e-01 | 0.029 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.418751e-01 | 0.026 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.532713e-01 | 0.021 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.551713e-01 | 0.020 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.609602e-01 | 0.017 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.707245e-01 | 0.013 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.809027e-01 | 0.008 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.845014e-01 | 0.007 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.902189e-01 | 0.004 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.964332e-01 | 0.002 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.976427e-01 | 0.001 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.986936e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.989380e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.991151e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.996844e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999982e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999994e-01 | 0.000 | 0 | 0 |